Lemaitre Vascular (LMAT) Tops Q2 EPS by 5c, Beats on Revenue; Offers FY24 Guidance

Lemaitre Vascular (NASDAQ: LMAT) reported Q2 EPS of $0.52, $0.05 better than the analyst estimate of $0.47. Revenue for the quarter came in at $55.8 million versus the consensus estimate of $54.98 million.

GUIDANCE:

Lemaitre Vascular sees FY2024 EPS of $1.82-$1.91, versus the consensus of $1.77. Lemaitre Vascular sees FY2024 revenue of $216.8-220.8 million, versus the consensus of $215 million.

For earnings history and earnings-related data on Lemaitre Vascular (LMAT) click here.

You May Also Be Interested In

• Movano (MOVE) Misses Q2 EPS by 195c
• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c